azabicyclische heterocyclen as modulators of the cannabinoidrezeptors

摘要

The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the general Formula I: including all prodrugs, pharmaceutically acceptable salts and stereoisomers, RSUP1/SUP, RSUP2/SUP, RSUP3/SUP, RSUP6/SUP, RSUP7/SUP, m and n are described herein.